Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.8B | 7.2B | 6.8B | 6.6B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.1B | 1.3B | 1.3B | 1.6B |
Other operating expenses | -9M | 0 | 4M | 9M |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 92M | 109M | 112M | 125M |
Other income expense | 11M | 5M | — | 2M |
Pretax income | 960M | 1.5B | 649M | 617M |
Tax provision | 262M | 599M | 168M | 142M |
Net income | 698M | 901M | 457M | -3.9B |
Basic EPS | — | 1.5 | 0.7 | -6.0 |
Diluted EPS | — | 1.4 | 0.7 | -6.0 |
Basic average shares | — | 606.2M | 641.6M | 661.1M |
Diluted average shares | — | 627.2M | 647.4M | 667.0M |
EBITDA | — | — | — | — |
Net income from continuing op. | 698M | 947M | 481M | -328M |
Minority interests | 0 | -3M | 2M | -93M |
Preferred stock dividends | — | — | — | — |